Addison Capital’s GENEREX BIOTECHNOLOGY CORP GNBT Stock Holding History

Addison Capital’s Portfolio GNBT Stock Details GNBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,000	Closed	–	–	119
2016 Q1	$0	Hold	10,000	–	–	﹤0.01%	116
2015 Q4	$0	Hold	10,000	–	–	﹤0.01%	110
2015 Q3	$0	Hold	10,000	–	–	﹤0.01%	97
2015 Q2	$0	Hold	10,000	–	–	﹤0.01%	106
2015 Q1	$0	Buy	+10,000	New	–	﹤0.01%	105
2014 Q2	–	Sell	-10,000	Closed	–	–	95
2014 Q1	$0	Hold	10,000	–	–	﹤0.01%	98
2013 Q4	$0	Buy	+10,000	New	–	﹤0.01%	94

Addison Capital's GNBT Position: Q2 2016 in Review

Addison Capital sold out of GENEREX BIOTECHNOLOGY CORP (GNBT) in Q2 2016, closing a stake of 10,000 shares.

Addison Capital first reported a position in GNBT in Q4 2013 and held it in 7 quarters. The position peaked at $0 in Q1 2016. 2 funds tracked by Wall St. Rank hold GNBT as of Q2 2016.

Addison Capital reported no remaining GENEREX BIOTECHNOLOGY CORP position as of Q2 2016 after selling out during the quarter.
Addison Capital sold 10,000 GENEREX BIOTECHNOLOGY CORP shares in Q2 2016.
Addison Capital first reported a position in GENEREX BIOTECHNOLOGY CORP in Q4 2013 and held it in 7 quarters.
Addison Capital's GENEREX BIOTECHNOLOGY CORP position peaked at $0 in Q1 2016.
2 funds tracked by Wall St. Rank held GENEREX BIOTECHNOLOGY CORP as of Q2 2016.

Based on Addison Capital's 13F filing for Q2 2016, filed 20 Jul 2016.